uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
The Cannabinoid Receptor-1 Is an Imaging Biomarker of Brown Adipose Tissue
Univ Turku, Turku PET Ctr, FI-20521 Turku, Finland.;Abo Akad Univ, Dept Biosci, Turku, Finland..
Univ Turku, Turku PET Ctr, FI-20521 Turku, Finland..
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology.
Univ Turku, Turku PET Ctr, FI-20521 Turku, Finland.;Univ Turku, Dept Psychiat, FI-20521 Turku, Finland..
Show others and affiliations
2015 (English)In: Journal of Nuclear Medicine, ISSN 0161-5505, E-ISSN 1535-5667, Vol. 56, no 12, 1937-1941 p.Article in journal (Refereed) PublishedText
Abstract [en]

Recently, the existence of significant deposits of brown adipose tissue (BAT) in human adults was confirmed. Its role in the human metabolism is unknown but could be substantial. Inhibition of the cannabinoid receptor-1 (CB1) by the antagonist rimonabant (SR141716) has been associated with activation of BAT thermogenesis and weight loss in mice and rats. The role of peripheral and central CB1 in the activation of BAT merits further investigation. Here we developed a technique for quantifying CB1 in BAT by PET. Methods: Sections of rat BAT and subcutaneous white adipose tissue (WAT) were stained for CB1 and uncoupling protein-1 by immunofluorescent staining. Binding of the radiolabeled CB1 antagonist (3R,5R)-5-(3-(18F-fluoromethoxy)phenyl)-3-(((R)-1-phenylethyl)amino)-1-(4-(trifluoromethyl)-phenyl)pyrrolidin-2-one (F-18-FMPEP-d(2)) to BAT in vivo and in vitro was assessed in rats by PET. Results: We found that CB1 was colocalized with uncoupling protein-1 in BAT, but neither protein was found in WAT. Binding of the radiotracer to BAT sections (but not WAT) in vitro was high and displaceable by pretreatment with rimonabant. Deposits of BAT in rats had significant binding of F-18-FMPEP-d(2) in vivo, indicating high CB1 density. WAT deposits were negative for F-18-FMPEP-d(2), consistent with the immunofluorescent staining and in vitro results. Conclusion: F-18-FMPEP-d(2) PET can quantify CB1 density noninvasively in vivo in rats. CB1 is therefore a promising surrogate imaging biomarker for assessing the presence of BAT deposits as well as for elucidating the mechanism of CB1 antagonist-mediated weight loss.

Place, publisher, year, edition, pages
2015. Vol. 56, no 12, 1937-1941 p.
Keyword [en]
brown adipose tissue, cannabinoid 1 receptor, F-18-FMPEP-d(2), positron emission tomography
National Category
Radiology, Nuclear Medicine and Medical Imaging
URN: urn:nbn:se:uu:diva-270949DOI: 10.2967/jnumed.115.156422ISI: 000365724800022PubMedID: 26359260OAI: oai:DiVA.org:uu-270949DiVA: diva2:890885
EU, FP7, Seventh Framework Programme
Available from: 2016-01-05 Created: 2016-01-05 Last updated: 2016-01-21Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Espes, Daniel
By organisation
Department of Medical Cell Biology
In the same journal
Journal of Nuclear Medicine
Radiology, Nuclear Medicine and Medical Imaging

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 192 hits
ReferencesLink to record
Permanent link

Direct link